Chemomab Therapeutics Ltd (STU:2QV0)
€ 1.66 -0.01 (-0.6%) Market Cap: 31.31 Mil Enterprise Value: 13.16 Mil PE Ratio: 0 PB Ratio: 2.07 GF Score: 35/100

Q1 2022 Chemomab Therapeutics Ltd Earnings Call Transcript

May 12, 2022 / 12:00PM GMT
Release Date Price: €2.48 (-5.34%)
Operator

Greetings, and welcome to the Chemomab first quarter 2022 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

I'd now like to turn the conference over to your host, Barbara Lindheim, Consulting Vice President, Strategic Communications for Chemomab. Thank you. You may begin.

Barbara Lindheim
Chemomab Therapeutics, Ltd. - Consulting VP, Strategic Communications

Welcome to the Chemomab Therapeutics 2022 first-quarter conference call. Thank you for attending. I am Barbara Lindheim, Consulting Vice President of Strategic Communications at Chemomab.

With me today are Dale Pfost, our Chairman and CEO; Don Marvin, CFO, Chief Operating Officer, and Executive Vice President; Dr. David Weiner, Interim CMO; and Dr. Adi Mor, our Co-Founder and Chief Scientific Officer.

Before turning the call over to Dale, please take note of our forward-looking statements. Today's call may contain forward-looking statements, which may be identified by words such as may, could, will, expect, intend, planned, and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot